Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.
| Revenue (TTM) | $26.93M |
| Gross Profit (TTM) | $4.74M |
| EBITDA | $-69.91M |
| Operating Margin | -595.00% |
| Return on Equity | -103.30% |
| Return on Assets | -13.70% |
| Revenue/Share (TTM) | $0.28 |
| Book Value | $2.29 |
| Price-to-Book | 2.45 |
| Price-to-Sales (TTM) | 23.10 |
| EV/Revenue | 25.26 |
| EV/EBITDA | -12.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 279.30% |
| Shares Outstanding | $125.90M |
| Float | $98.40M |
| % Insiders | 13.12% |
| % Institutions | 57.55% |
Volatility is currently contracting
Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen's Virginia Gas Project
ASP Isotopes has previously announced that it has signed three commercial contracts for the supply of enriched Silicon-28 to U.S.-based customers, and expects to make initial commercial shipments of enriched Silicon-28 in Q3 2026. The first 18 stages (comprising segments one and two) of the Silicon-28 enrichment facility have now successfully operated for over three weeks at target enrichment levels.
MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028 MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028
Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy
First Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equivalents and Short-Term Marketable Securities of $333 million as of December 31, 2025 Business Update Conference Call Scheduled for 8:00 AM ET on April 13, 2026 DALLAS, April 13, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today provided a business update highlighting operational progress across its nuclear medicine, electronics, and nuclear energy platforms. “2026 is the year we expect to showcase our technology at scale.
DALLAS, April 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Paul Mann, Executive Chairman and Chief Executive Officer at ASP Isotopes, will host a business update conference call and webcast on Monday, April 13, 2026, at 8:00 AM ET.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Philadelphia, Pennsylvania--(Newsfile Corp. - March 26, 2026) - What is Happening? Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI).
